Search Results for: LRP1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
LRPAP1 LDL receptor related protein associated protein 1
LTF lactotransferrin
  • Mtb iron assimilation by chelation
  • Neutrophil degranulation
  • Metal sequestration by antimicrobial proteins
  • Antimicrobial peptides
  • Amyloid fiber formation
  • 3h-Indole-5,6-Diol
  • Lauric acid
  • Nitrilotriacetic acid
  • alpha-D-Fucopyranose
  • Nimesulide
  • (R)-Atenolol
  • Parecoxib
MAPK8IP1 mitogen-activated protein kinase 8 interacting protein 1
  • Pyrazolanthrone
  • 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE
  • N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE
  • 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE
  • Anthralin
MAPK8IP2 mitogen-activated protein kinase 8 interacting protein 2
MAPRE1 microtubule associated protein RP/EB family member 1
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases Activate Formins
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • EML4 and NUDC in mitotic spindle formation
MDK midkine
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
MMP13 matrix metallopeptidase 13
  • Collagen degradation
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Assembly of collagen fibrils and other multimeric structures
  • RUNX2 regulates genes involved in cell migration
  • Marimastat
  • 3-Methylpyridine
  • 2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide
  • WAY-151693
  • Hydroxyaminovaline
  • 4-methoxybenzenesulfinate
  • PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)
  • PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)
  • PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]
  • Endostatin
  • TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE
  • 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
  • 5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
  • CTS-1027
  • BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
MMP14 matrix metallopeptidase 14
  • Collagen degradation
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Marimastat
MMP15 matrix metallopeptidase 15
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Marimastat
MMP16 matrix metallopeptidase 16
  • Activation of Matrix Metalloproteinases
  • Marimastat
  • Batimastat
MMP17 matrix metallopeptidase 17
  • Activation of Matrix Metalloproteinases
  • Marimastat
MTDH metadherin
NGF nerve growth factor
  • PLC-gamma1 signalling
  • Signalling to RAS
  • NGF processing
  • NGF processing
  • Frs2-mediated activation
  • Frs2-mediated activation
  • ARMS-mediated activation
  • ARMS-mediated activation
  • Retrograde neurotrophin signalling
  • Retrograde neurotrophin signalling
  • TRKA activation by NGF
  • TRKA activation by NGF
  • Signalling to p38 via RIT and RIN
  • NRAGE signals death through JNK
  • p75NTR negatively regulates cell cycle via SC1
  • Ceramide signalling
  • PI3K/AKT activation
  • PI3K/AKT activation
  • Signalling to STAT3
  • NFG and proNGF binds to p75NTR
  • NADE modulates death signalling
  • NRIF signals cell death from the nucleus
  • NRIF signals cell death from the nucleus
  • p75NTR recruits signalling complexes
  • p75NTR recruits signalling complexes
  • NF-kB is activated and signals survival
  • Axonal growth stimulation
  • Clenbuterol
  • RI 624
  • Polaprezinc
NOS1AP nitric oxide synthase 1 adaptor protein
NTF3 neurotrophin 3
  • NTF3 activates NTRK2 (TRKB) signaling
  • NTF3 activates NTRK3 signaling
  • NTF3 activates NTRK3 signaling
  • Signaling by NTRK3 (TRKC)
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through RAS
  • Activated NTRK3 signals through PI3K
  • Activated NTRK3 signals through PI3K
NTF4 neurotrophin 4
  • NTF4 activates NTRK2 (TRKB) signaling
  • Activated NTRK2 signals through RAS
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PI3K
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK2 signals through FRS2 and FRS3
  • Primary open angle glaucoma
PDGFB platelet derived growth factor subunit B
  • Platelet degranulation
  • PIP3 activates AKT signaling
  • Downstream signal transduction
  • Signaling by PDGF
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Non-integrin membrane-ECM interactions
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Pegpleranib
  • Malignant pleural mesothelioma
  • Glioma
PID1 phosphotyrosine interaction domain containing 1
PLAT plasminogen activator, tissue type
  • Signaling by PDGF
  • Dissolution of Fibrin Clot
  • Aminocaproic acid
  • Iloprost
  • Human C1-esterase inhibitor
  • 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID
  • Dexibuprofen
  • Conestat alfa
PLAUR plasminogen activator, urokinase receptor
  • Attachment of GPI anchor to uPAR
  • Neutrophil degranulation
  • Dissolution of Fibrin Clot
  • Alteplase
  • Urokinase
  • Tenecteplase
  • WX-UK1
  • Lanoteplase

Page 3 out of 4 pages